Marek Borský
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 18
- Chronic Lymphocytic Leukemia Research 16
-
- Wnt/β-catenin signaling in development and cancer 2
- Co-authors
- Libor Kozák (1 shared paper)Jiřı́ Mayer (17 shared papers)Michael Doubek (13 shared papers)Šárka Pospı́šilová (11 shared papers)Yvona Brychtová (12 shared papers)Marek Mráz (5 shared papers)Martin Trbušek (7 shared papers)Kateřina Amruz Černá (3 shared papers)
- Journals
- Blood (2 papers)Experimental Hematology (2 papers)Oncotarget (2 papers)Clinical Cancer Research (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- CzechiaSlovakiaUnited States
In The Last Decade
Marek Borský
26 papers receiving 547 citations
Peers
Comparison fields: 5 of 53
- Genetics 188
- Hematology 138
- Nutrition and Dietetics 108
- Pathology and Forensic Medicine 111
- Health, Toxicology and Mutagenesis 81
Countries citing papers authored by Marek Borský
This map shows the geographic impact of Marek Borský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Borský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Borský more than expected).
Fields of papers citing papers by Marek Borský
This network shows the impact of papers produced by Marek Borský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Borský. The network helps show where Marek Borský may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Borský, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 107 | |
| 2 | 2016 | 83 | |
| 3 | 2012 | 75 | |
| 4 | 2015 | 52 | |
| 5 | 2016 | 29 | |
| 6 | 2009 | 24 | |
| 7 | 2019 | 22 | |
| 8 | Telomerase as a diagnostic and predictive marker in colorectal carcinoma. | 2004 | 22 |
| 9 | 2018 | 20 | |
| 10 | Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells. | 2003 | 19 |
| 11 | 2016 | 17 | |
| 12 | 2010 | 16 | |
| 13 | 2013 | 12 | |
| 14 | 2013 | 11 | |
| 15 | 2008 | 10 | |
| 16 | 2014 | 10 | |
| 17 | 2016 | 10 | |
| 18 | 2009 | 5 | |
| 19 | 2022 | 3 | |
| 20 | 2012 | 2 |
About Marek Borský
Marek Borský is a scholar working on Genetics, Molecular Biology, Hematology, Immunology and Pathology and Forensic Medicine, having authored 26 papers that have together received 556 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Cancer-related Molecular Pathways (4 papers), Galectins and Cancer Biology (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Genetics (188 citations), Hematology (138 citations), Nutrition and Dietetics (108 citations), Pathology and Forensic Medicine (111 citations) and Health, Toxicology and Mutagenesis (81 citations). Marek Borský has collaborated with scholars based in Czechia, Slovakia and United States. Frequent co-authors include Libor Kozák, Jiřı́ Mayer, Michael Doubek, Šárka Pospı́šilová, Yvona Brychtová, Marek Mráz, Martin Trbušek, Kateřina Amruz Černá, Václav Šeda and Karla Plevová. Their work appears in journals such as Blood, Experimental Hematology, Oncotarget, Clinical Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.